Columbus, OH – On September 10-12, 2025, the inaugural analytica USA will host over 260 exhibitors at the Greater Columbus Convention Center, offering a premier platform for technologies and solutions critical to the drug discovery pipeline. The event's accompanying scientific conference and hands-on special shows will provide crucial insights for professionals in pharmaceutical research, preclinical development, and biomanufacturing.
The analytica conference will feature an array of scientific talks directly relevant to drug development. John McLean of Vanderbilt University will deliver a keynote on Phenomics, a field that connects genetic makeup to observable traits. This research, utilizing advanced bioanalytics and AI, is foundational for developing more effective personalized medicine and predicting disease progression. The conference will also highlight advanced applications in RNA analysis and the study of platelets using mass spectrometry — both essential for understanding disease mechanisms and drug effects.
In addition, the conference program will cover the latest in multiomics techniques and 3D cell cultures, which are vital tools for building more accurate in-vitro models for drug screening. Discussions on liquid chromatography (LC), including multidimensional and capillary LC, will address the need for greater sensitivity and specificity in analyzing complex biological samples.
The Digital Transformation special show will demonstrate how the lab of tomorrow can streamline biopharmaceutical workflows. A key highlight is the Smart Cold Chain Workflow, which showcases the automated handling of temperature-sensitive samples — a critical process for maintaining the integrity of biologics and reagents. This demonstration combines a collaborative robot from Universal Robots with intelligent stirring, cooling devices from Liebherr, and control systems, all unified by a Laboratory Execution System from SmartLab Solutions. This integrated approach minimizes human error and ensures strict adherence to temperature-controlled protocols, which is vital for regulatory compliance and product quality.
A separate demonstration will show a fully autonomous titration process, providing a powerful example of how robotics can free up researchers from repetitive tasks, allowing them to focus on more complex, high-value work in the drug discovery process.
analytica USA's unique blend of cutting-edge research and practical technological demonstrations offers an unparalleled opportunity for the drug discovery community to discover new tools and methodologies that can accelerate the path from lab bench to patient.
Find out more about: https://analytica-us.com/en/
